BioAmber (BIOA) Tops Q1 EPS by 13c

BioAmber (NYSE: BIOA) reported Q1 EPS of $0.00, $0.13 better than the analyst estimate of ($0.13). Revenue for the quarter came in at $2.12 million versus the consensus estimate of $4.02 million.

For earnings history and earnings-related data on BioAmber (BIOA) click here.

You May Also Be Interested In

• FedEx falls 4% as FY2027 profit forecast misses expectations despite Q4 beat
• Nike names former Pfizer CFO David Denton as new finance chief
• After-Hours Stock Movers: FDX, CBRS, NKE